FDA granted accelerated approval to retifanlimab-dlwr for Merkel cell carcinoma in 2023Nov 12Regulatory decisionIncyte Corporationretifanlimab
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Oncolytics reports durability and survival data for pelareorep in anal cancerOct 27Regulatory decisionOncolytics Biotechpelareorep
Incyte posts results for Phase 1/2 anti-PD-1, LAG-3, TIM-3 combo trial in advanced malignanciesAug 17Trial updateINCAGN02385INCAGN02390
Incyte-linked filings this week: FIGHT-302 results posted, new academic pancreatic trial listedAug 14Weekly roundup, 2 itemsIncyte Corporationpemigatinib